RxDoctor Payments Data

Randy Cronic, MD

Family Medicine · Duluth, GANPI 1063438679

Payments from drug & device makers

$1,406in general payments, 2019–2025

Across 70 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$143
  • AbbVie$140
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$117
  • Pfizer$102
  • Novo Nordisk$93
  • Amgen$84
  • plus $726 from 23 others

What the payments were for

  • Food & beverage$1,406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,406 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$273,028
Medicare patients
689
Services billed
2,713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban115$87,671
MounjaroTirzepatide62$76,255
XifaxanRifaximin26$61,738
JanuviaSitagliptin Phosphate51$53,065
OzempicSemaglutide31$42,784
XareltoRivaroxaban43$27,261
JanumetSitagliptin Phos/Metformin Hcl23$19,239
RexultiBrexpiprazole12$18,698
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,884
Tresiba Flextouch U-100Insulin Degludec15$14,526
FarxigaDapagliflozin Propanediol11$12,048
MyrbetriqMirabegron38$11,689
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$11,287
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen397$10,691
Levothyroxine Sodium620$6,266

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$102$87,671115 claims
Lilly USA, LLCMounjaro$39$76,25562 claims
MerckJanuvia, Janumet$33$72,30474 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$117$61,73826 claims
Novo NordiskOzempic$93$42,78431 claims
GSKTrelegy Ellipta, Breo Ellipta$19$19,60135 claims
Otsuka America Pharmaceutical, Inc.Rexulti$143$18,69812 claims
AbbVieSynthroid$140$5,90272 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Duluth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →